Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas

Clinical trial NCT01338857 · TERMINATED

Trial details

NCT number: NCT01338857
Sponsor: NYU Langone Health
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

neurofibromatosis1 (NF1)Recurrent or Progressive Optic Pathway Gliomas (OPG)Recurrent or Progressive Low-grade Glioma

Start date: 2011-04-01
Primary completion: 2013-03-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.